Moderna Inc (NASDAQ:MRNA)

173.21
Delayed Data
As of Feb 03
 -3.10 / -1.76%
Today’s Change
115.03
Today|||52-Week Range
217.25
-3.57%
Year-to-Date
Top 5 4th Quarter Trades of Lipe & Dalton
Feb 03 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights Pfizer/BioNTech, Moderna and Novavax
Jan 30 / Zacks.com - Paid Partner Content
3 No-Brainer Growth Stocks to Buy in 2023
Feb 03 / MotleyFool.com - Paid Partner Content
2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
Jan 29 / MotleyFool.com - Paid Partner Content
Is Moderna Stock a Buy Now?
Feb 03 / MotleyFool.com - Paid Partner Content
Novavax (NVAX) COVID Jab Aids Growth, Overdependence a Challenge (revised)
Jan 27 / Zacks.com - Paid Partner Content
Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know
Feb 01 / Zacks.com - Paid Partner Content
FDA Panel Endorses Simplification of COVID-19 Vaccine Strategy
Jan 27 / Zacks.com - Paid Partner Content
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
Feb 01 / MotleyFool.com - Paid Partner Content
Moderna (MRNA) Gains But Lags Market: What You Should Know
Jan 26 / Zacks.com - Paid Partner Content
Top 5 4th Quarter Trades of REIK & CO., LLC
Jan 31 / GuruFocus News - Paid Partner Content
2 Top Biotech Stocks to Buy for the Long Haul
Jan 26 / MotleyFool.com - Paid Partner Content
This Discount Growth Stock Is a Once-in-a-Decade Buying Opportunity Right Now
Jan 31 / MotleyFool.com - Paid Partner Content
Novavax (NVAX) COVID Jab Aids Growth, Overdependence A Woe
Jan 26 / Zacks.com - Paid Partner Content
Moderna (MRNA) RSV Jab For Older Adults Gets FDA Breakthrough Tag
Jan 31 / Zacks.com - Paid Partner Content
Could This RSV News Make Moderna a Hot Buy Again?
Jan 25 / MotleyFool.com - Paid Partner Content
The Covid sales boom is over for Pfizer
Jan 31 / CNN.com
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know
Jan 25 / Zacks.com - Paid Partner Content